Form 4: Director Allan Selig Boosts Marcus Corp. Stake
Insider Transaction Report
Marcus Corporation Director Allan H. Selig reported the acquisition of 4,174 shares of common stock through a restricted stock grant.
Summary
- Allan H. Selig, a Director of The Marcus Corporation (MCS), acquired 4,174 shares of common stock.
- The acquisition occurred on December 31, 2025, as a restricted stock grant with a price of $0 per share.
- Following this transaction, Selig beneficially owns 63,924 shares of common stock directly.
- The restricted stock vests 50% after the second anniversary and 100% after the fourth anniversary of the grant date.
- Selig also holds several stock options granted under The Marcus Corporation 2004 Equity and Incentive Awards Plan, with various strike prices and expiration dates.
Sentiment
Score: 7
Explanation: The acquisition of restricted stock by a director is generally a positive signal, indicating continued alignment of management interests with the company's long-term performance. The $0 price suggests it's a compensation grant, which is standard practice.
Positives
- Director Allan H. Selig increased his direct beneficial ownership in The Marcus Corporation by 4,174 shares of common stock.
- The acquisition was a restricted stock grant, aligning management interests with shareholder value.
Future Outlook
The restricted stock granted on December 31, 2025, is scheduled to vest 50% after its second anniversary and 100% after its fourth anniversary, indicating future equity ownership for the director.
Industry Context
Insider transactions, such as director stock grants, are common mechanisms for aligning the interests of company leadership with long-term shareholder value in the entertainment and hospitality industry, where The Marcus Corporation operates. These grants often form a significant part of executive compensation packages.
Stakeholder Impact
- Shareholders: Increased alignment of a director's interests with shareholder value through equity ownership.
Next Steps
- Vesting of 50% of the restricted stock after December 31, 2027 (2nd anniversary).
- Vesting of the remaining 50% (100% total) of the restricted stock after December 31, 2029 (4th anniversary).
Key Dates
| Date | Description |
|---|---|
| 12/29/2016 | Date exercisable for a stock option with a strike price of $31.55. |
| 12/28/2017 | Date exercisable for a stock option with a strike price of $27.20. |
| 12/27/2018 | Date exercisable for a stock option with a strike price of $38.51. |
| 12/26/2019 | Date exercisable for a stock option with a strike price of $32.60. |
| 12/30/2021 | Date exercisable for a stock option with a strike price of $17.95. |
| 12/28/2022 | Date exercisable for a stock option with a strike price of $14.25. |
| 12/28/2023 | Date exercisable for a stock option with a strike price of $14.69. |
| 12/31/2025 | Date of restricted stock grant acquisition. |
| 01/05/2026 | Signature date of the reporting person's attorney-in-fact. |
| 12/29/2026 | Expiration date for a stock option with a strike price of $31.55. |
| 12/28/2027 | Expiration date for a stock option with a strike price of $27.20. |
| 12/27/2028 | Expiration date for a stock option with a strike price of $38.51. |
| 12/26/2029 | Expiration date for a stock option with a strike price of $32.60. |
| 12/30/2031 | Expiration date for a stock option with a strike price of $17.95. |
| 12/29/2032 | Expiration date for a stock option with a strike price of $14.25. |
| 12/28/2033 | Expiration date for a stock option with a strike price of $14.69. |
Recommendation
holdThis Form 4 filing reports a routine restricted stock grant to a director, which is a standard compensation practice aimed at aligning management incentives with long-term company performance. It does not provide new operational or financial performance data that would warrant a change in investment recommendation. The transaction itself is a neutral to slightly positive signal for long-term alignment, but not a catalyst for immediate action.
Keywords
Marcus Corporation, MCS, Allan H. Selig, Form 4, Insider Trading, Restricted Stock, Stock Grant, Director Ownership, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.